KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

UiPath (PATH) Cash & Equivalents (2021 - 2026)

UiPath filings provide 6 years of Cash & Equivalents readings, the most recent being $871.2 million for Q1 2026.

  • Quarterly Cash & Equivalents fell 0.91% to $871.2 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $871.2 million through Jan 2026, down 0.91% year-over-year, with the annual reading at $871.2 million for FY2026, 0.91% down from the prior year.
  • Cash & Equivalents hit $871.2 million in Q1 2026 for UiPath, up from $743.7 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $1.8 billion in Q1 2022 and bottomed at $628.6 million in Q3 2025.
  • Average Cash & Equivalents over 5 years is $1.1 billion, with a median of $1.1 billion recorded in 2024.
  • The largest annual shift saw Cash & Equivalents skyrocketed 394.48% in 2022 before it tumbled 38.89% in 2025.
  • UiPath's Cash & Equivalents stood at $1.5 billion in 2022, then crashed by 30.88% to $1.0 billion in 2023, then decreased by 22.87% to $773.6 million in 2024, then decreased by 3.87% to $743.7 million in 2025, then grew by 17.14% to $871.2 million in 2026.
  • Per Business Quant, the three most recent readings for PATH's Cash & Equivalents are $871.2 million (Q1 2026), $743.7 million (Q4 2025), and $628.6 million (Q3 2025).